Access to investigational therapies

At Exelixis, we are focused on providing patients access to our investigational medicines when it is appropriate. Requests for investigational medicines, which are medications that have not received regulatory approval, are called “early access” requests. Clinical trials and early access are two potential ways patients can access investigational medicines.

You are now leaving the website. This link will take you to a website to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website.